Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-033625
Filing Date
2012-05-31
Accepted
2012-05-31 14:02:08
Documents
1
Period of Report
2012-05-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd346940.html 4  
1 FORM 4 rrd346940.xml 4 3763
  Complete submission text file 0001181431-12-033625.txt   5101
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 950 PARK AVE APT. 11A NEW YORK NY 10028
Business Address
KESSEL MARK (Reporting) CIK: 0001222013 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 12880166